The significance of the site of recurrence to subsequent breast cancer survival
- PMID: 17049430
- DOI: 10.1016/j.ejso.2006.09.005
The significance of the site of recurrence to subsequent breast cancer survival
Abstract
Aim: To investigate differences in the 3-year survival of patients with recurrent breast cancer dependent on recurrence site.
Methods: The study was a review of 294 patients from a breast cancer database, who were treated for operable breast cancer and subsequently developed a recurrence between 1989 and 2003. Patients were divided into four groups according to the site of first recurrence (local, lymph node, bone or visceral). Breast Cancer Specific Survival (BCSS) was compared using Kaplan-Meier life table analysis and the log rank test.
Results: Patient and tumour characteristics were comparable between the four groups. Survival rates between the recurrence site groups were significantly different. Patients in whom first recurrence was local had the best prognosis with a 3-year BCSS of 83% compared to 33% for patients with first node recurrence (p<0.001), 23% for patients with first bone recurrence (p=0.03) and 13% for patients with first visceral recurrence (p=0.004).
Conclusion: Survival of patients with recurrent breast cancer is associated with the site of first recurrence. The prognosis from recurrence is progressively worse with local, regional, bone and visceral metastasis.
Similar articles
-
[Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].Magy Onkol. 2007;51(2):127-31. Epub 2007 Jul 29. Magy Onkol. 2007. PMID: 17660868 Hungarian.
-
[Locoregional recurrences of breast cancer].J Gynecol Obstet Biol Reprod (Paris). 1995;24(1):13-8. J Gynecol Obstet Biol Reprod (Paris). 1995. PMID: 7730560 French.
-
[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18353207 Chinese.
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
Principles of adjuvant therapy.Br J Hosp Med. 1995 Sep 20-Oct 3;54(6):249-54. Br J Hosp Med. 1995. PMID: 8542172 Review.
Cited by
-
Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis.Breast Cancer Res Treat. 2013 Apr;138(3):829-37. doi: 10.1007/s10549-013-2447-8. Epub 2013 Apr 6. Breast Cancer Res Treat. 2013. PMID: 23563958 Free PMC article. Clinical Trial.
-
The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy.Ann Surg Oncol. 2020 Aug;27(8):2711-2720. doi: 10.1245/s10434-020-08310-2. Epub 2020 Mar 10. Ann Surg Oncol. 2020. PMID: 32157524
-
Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.Clin Exp Metastasis. 2009;26(2):97-103. doi: 10.1007/s10585-008-9219-6. Epub 2008 Oct 22. Clin Exp Metastasis. 2009. PMID: 18941910
-
Cryo-Assisted Resection En Bloc, and Cryoablation In Situ, of Primary Breast Cancer Coupled With Intraoperative Ultrasound-Guided Tracer Injection: A Preliminary Clinical Study.Technol Cancer Res Treat. 2018 Jan 1;17:1533034617746294. doi: 10.1177/1533034617746294. Technol Cancer Res Treat. 2018. PMID: 29347887 Free PMC article.
-
Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population.J Cancer Epidemiol. 2014;2014:170634. doi: 10.1155/2014/170634. Epub 2014 Jan 9. J Cancer Epidemiol. 2014. PMID: 24527034 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
